Welcome to Medications.com

Lilly and Daiichi Sankyo's prasugrel NDA gets priority review - Pharma Times (subscription)

The NDA for prasugrel, which if approved will compete with Plavix (clopidogrel), Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster, was submitted to the ...

http://www.pharmatimes.com/WorldN... | Posted: Fri Feb 22 05:55:52 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea